Clinical trial
A Study to Evaluate Safety and Efficacy of Clobetasol Propionate for Treatment of Plaque-Type Psoriasis in Adult Subjects.
NCT00852761 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate Safety and Efficacy of Clobetasol Propionate for Treatment of Plaque-Type Psoriasis in Adult Subjects.
- Lead sponsor
- Stiefel, a GSK Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- August 31, 2009
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plaque-type psoriasis